Apoptosis

Apoptosis(凋亡)

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

研究方向

Apoptosis 相关产品(2721)

  • GC68305 structure
    GC68305Dacetuzumab
    CAS: 880486-59-9

    Dacetuzumab (SGN-40) 是一种人源化的 IgG1,抗 CD40单克隆抗体,具有抗淋巴瘤活性。Dacetuzumab 通过免疫效应作用(抗体依赖性细胞毒性和吞噬作用[ADCC/ADCP]) 杀死肿瘤细胞。Dacetuzumab ((SGN-40) 可用于多发性骨髓瘤研究。

  • GC68306 structure
    GC68306Deoxynyboquinone
    CAS: 96748-86-6

    Deoxynyboquinone 是 NQO1 的底物,是有效的抗癌剂。Deoxynyboquinone 诱导癌症细胞凋亡 (Apoptosis)。Deoxynyboquinone 通过氧化应激和活性氧 (ROS) 的形成杀死癌细胞。

  • GC68308 structure
    GC68308Bisdemethoxycurcumin-d8
    CAS: 2470233-08-8

    Bisdemethoxycurcumin-d8 (Curcumin III-d8) 是 Bisdemethoxycurcumin 的氘代物。Bisdemethoxycurcumin 是姜黄素衍生物,具有抗炎症和抗癌活性。

  • GC68369 structure
    GC68369Belantamab
    CAS: 2061894-48-0

    Belantamab (GSK2857914) 是一种人源化 IgG1 抗 BCMA (TNFRSF17) 单克隆抗体。Belantamab 可用于合成抗体-药物偶联物 (ADC),Belantamab mafodotin。

  • GC68371 structure
    GC68371Mutant p53 modulator-1
    CAS: 2746371-35-5

    Mutant p53 modulator-1 是一种突变型 p53 调节剂。Mutant p53 modulator-1 可减少含有 p53 突变的癌症的进展 (摘自专利 WO2021231474A1,化合物 231B)。

  • GC68385 structure
    GC68385TNF-α-IN-6
    CAS: 2699704-20-4

    TNF-α-IN-6 是一种口服有效的 TNFα 的变构抑制剂(KD = 6.8 nM)。

  • GC68388 structure
    GC68388XIAP degrader-1
    CAS: 2803617-91-4

    XIAP degrader-1 是一种伯胺小分子,可促进X-连锁凋亡抑制蛋白(XIAP)的降解。

  • GC68404 structure
    GC68404Human PD-L1 inhibitor IV
    CAS: 2135542-83-3

    Human PD-L1 inhibitor IV 是一种竞争性的 human PD-1 protein 抑制剂,Kd 值为 1.38 μM,可抑制人 PD-1/PD-L1 的结合。

  • GC68452 structure
    GC684522,4,6-Triiodophenol
    CAS: 609-23-4
    纯度: >98.00%

    2,4,6-Triiodophenol 是一种具有口服活性的、强效的 leukotriene B4 (LTB4) 合成抑制剂。2,4,6-Triiodophenol 可诱导小鼠囊胚凋亡。

  • GC68470 structure
    GC68470SPD304 dihydrochloride
    CAS: 1049741-03-8
    纯度: >99.00%

    SPD304是一种选择性的肿瘤坏死因子α(TNF-α)抑制剂,IC 50 值为22μM。

  • GC68537 structure
    GC685373-IN-PP1
    CAS: 2227110-54-3

    3-IN-PP1 是一种蛋白激酶 D (PKD) 抑制剂。 3-IN-PP1 对 PKD1、PKD2 和 PKD3 具有有效广泛的 PKD 抑制活性, IC50 值分别为 108、94 和 108 nM。3-IN-PP1 也是一种广谱抗癌剂,对多种肿瘤细胞的生长有抑制作用。3-IN-PP1 可用于癌症研究。

  • GC68562 structure
    GC685625-Aminolevulinic acid-13C-1 hydrochloride
    CAS: 129720-94-1
    纯度: >98.00%

    5-Aminolevulinic acid-13C-1 (5-ALA-13C-1) hydrochloride 是 13C 标记的 5-Aminolevulinic acid hydrochloride。5-Aminolevulinic acid hydrochloride (5-ALA hydrochloride) 是体内血红素生物合成的中间体,为四吡咯的前体。

  • GC68600 structure
    GC68600Ac-DEVD-CMK TFA
    纯度: >99.00%

    Ac-DEVD-CMK (Caspase-3 Inhibitor III) TFA 是一种选择性且不可逆的 caspase-3 抑制剂。Ac-DEVD-CMK TFA 显着抑制由高水平葡萄糖或 3,20-dibenzoate (IDB; 5) 诱导的凋亡。Ac-DEVD-CMK TFA 可以用于多种实验方法以抑制细胞凋亡。

  • GC68621 structure
    GC68621Ac-WEHD-AFC TFA
    纯度: >98.00%

    Ac-WEHD-AFC TFA 是一种荧光 caspase-1 底物。Ac-WEHD-AFC TFA 可检测 caspase-1 荧光活性,用于肿瘤和炎症的研究。

  • GC68632 structure
    GC68632AK-778-XXMU
    CAS: 1227045-76-2
    纯度: >98.50%

    AK-778-XXMU是DNA结合2 (ID2) 拮抗剂的有效抑制剂,KD为129 nM。AK-778-XXMU 能抑制胶质瘤细胞株的迁移和侵袭,诱导细胞凋亡 (apoptosis),更重要的是能减缓肿瘤生长。

  • GC68700 structure
    GC68700ASR-488
    CAS: 2690312-65-1
    纯度: >99.00%

    ASR-488 可激活 mRNA 结合蛋白 CPEB1,诱导细胞凋亡 (apoptosis) 并抑制膀胱癌的生长。

  • GC68729 structure
    GC68729Bax activator-1
    CAS: 1638526-94-9
    纯度: >98.00%

    Bax activator-1 (compound 106) 是一种 Bax 激活剂,诱导 Bax 依赖性肿瘤细胞凋亡。

  • GC68744 structure
    GC68744BC-?1258
    CAS: 1507370-40-2

    BC-1258 是一种 F-box/LRR-重复蛋白 2 (FBXL2) 激活剂,可以稳定和上调 FBXL2 水平。BC-1258 诱导致瘤细胞凋亡,并显着抑制小鼠的肿瘤形成。

  • GC68757 structure
    GC68757BH3 hydrochloride
    纯度: >98.00%

    BH3 hydrochloride 是能透过血脑屏障的多肽,通过直接激活促凋亡 Bax/Bak 或通过中和抗凋亡 Bcl-2 蛋白 (Bcl-2、Bcl-XL、Bcl-w、mcl1和A-1)来诱导细胞凋亡,通过与BH3 结构域结合。

  • GC68765 structure
    GC68765Bim-IN-1
    CAS: 2909483-36-7
    纯度: >99.00%

    Bim-IN-1 是一种有效的 Bim 表达抑制剂,Bim-IN-1 能够降低 Bim 的表达水平且对蛋白激酶 A 几乎没有抑制作用,同时也具有较低的毒性。

  • GC68769 structure
    GC68769Biotin-COG1410 TFA
    纯度: >99.00%

    Biotin-COG1410 TFA 是生物素化的 COG1410 。COG1410 是一种载脂蛋白 E 的衍生肽和凋亡 (apoptosis) 抑制剂。COG1410 在小鼠颅脑损伤 (TBI) 模型中发挥神经保护和抗炎作用。COG1410 可用于神经系统疾病的研究。

  • GC68774 structure
    GC68774Bleomycin A5
    CAS: 11116-32-8

    Bleomycin A5 (Pingyangmycin) 是糖肽类抗生素,具有口服活性。Bleomycin A5 具有抗肿瘤剂、细胞凋亡诱导剂和细菌代谢物的作用。

  • GC68787 structure
    GC68787Boc-Asp(OMe)-fluoromethyl ketone
    CAS: 187389-53-3

    Boc-Asp(OME)-Fluoromethyl Keton 是一种广泛的 caspase 抑制剂,可抑制 Fas 介导的吞噬作用和氧化破裂抑制,但不影响 IL-8 的趋化活性。

  • GC68815 structure
    GC68815Budigalimab
    CAS: 2098225-93-3

    Budigalimab (ABBV 181; PR 1648817) 是一种人源 IgG1 单克隆抗体,靶向程序性细胞死亡 1 (PD-1) 受体。Budigalimab 具有 Fc 突变,从而减少了 Fc 受体相互作用和效应因子的抑制作用。